1086 related articles for article (PubMed ID: 24225494)
1. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways.
Zhang XJ; He C; Tian K; Li P; Su H; Wan JB
Vascul Pharmacol; 2015 Oct; 73():86-95. PubMed ID: 25912763
[TBL] [Abstract][Full Text] [Related]
3. Fucoidan attenuates angiotensin II-induced abdominal aortic aneurysms through the inhibition of c-Jun N-terminal kinase and nuclear factor κB activation.
Tsai SH; Wang JC; Liao WI; Hsu YJ; Lin CY; Liao MT; Huang PH; Lin SJ
J Vasc Surg; 2018 Dec; 68(6S):72S-81S.e1. PubMed ID: 29290496
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D Receptor Activation Reduces Angiotensin-II-Induced Dissecting Abdominal Aortic Aneurysm in Apolipoprotein E-Knockout Mice.
Martorell S; Hueso L; Gonzalez-Navarro H; Collado A; Sanz MJ; Piqueras L
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1587-97. PubMed ID: 27283745
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl peptidase-4 inhibitor decreases abdominal aortic aneurysm formation through GLP-1-dependent monocytic activity in mice.
Lu HY; Huang CY; Shih CM; Chang WH; Tsai CS; Lin FY; Shih CC
PLoS One; 2015; 10(4):e0121077. PubMed ID: 25876091
[TBL] [Abstract][Full Text] [Related]
6. Exploration of the mechanisms by which 3,4-benzopyrene promotes angiotensin II-induced abdominal aortic aneurysm formation in mice.
Ji K; Zhang Y; Jiang F; Qian L; Guo H; Hu J; Liao L; Tang J
J Vasc Surg; 2014 Feb; 59(2):492-9. PubMed ID: 23676189
[TBL] [Abstract][Full Text] [Related]
7. Smooth muscle cell deletion of low-density lipoprotein receptor-related protein 1 augments angiotensin II-induced superior mesenteric arterial and ascending aortic aneurysms.
Davis FM; Rateri DL; Balakrishnan A; Howatt DA; Strickland DK; Muratoglu SC; Haggerty CM; Fornwalt BK; Cassis LA; Daugherty A
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):155-62. PubMed ID: 25395615
[TBL] [Abstract][Full Text] [Related]
8. Effects of chymase inhibitor on angiotensin II-induced abdominal aortic aneurysm development in apolipoprotein E-deficient mice.
Inoue N; Muramatsu M; Jin D; Takai S; Hayashi T; Katayama H; Kitaura Y; Tamai H; Miyazaki M
Atherosclerosis; 2009 Jun; 204(2):359-64. PubMed ID: 18996524
[TBL] [Abstract][Full Text] [Related]
9. Cilostazol Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysms but Not Atherosclerosis in Apolipoprotein E-Deficient Mice.
Umebayashi R; Uchida HA; Kakio Y; Subramanian V; Daugherty A; Wada J
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):903-912. PubMed ID: 29437572
[TBL] [Abstract][Full Text] [Related]
10. PARP-1 (Poly[ADP-Ribose] Polymerase 1) Inhibition Protects From Ang II (Angiotensin II)-Induced Abdominal Aortic Aneurysm in Mice.
Liang ES; Bai WW; Wang H; Zhang JN; Zhang F; Ma Y; Jiang F; Yin M; Zhang MX; Chen XM; Qin WD
Hypertension; 2018 Nov; 72(5):1189-1199. PubMed ID: 30354818
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of development of abdominal aortic aneurysm by glycolysis restriction.
Tsuruda T; Hatakeyama K; Nagamachi S; Sekita Y; Sakamoto S; Endo GJ; Nishimura M; Matsuyama M; Yoshimura K; Sato Y; Onitsuka T; Imamura T; Asada Y; Kitamura K
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1410-7. PubMed ID: 22499992
[TBL] [Abstract][Full Text] [Related]
12. Genetic Ablation of MicroRNA-33 Attenuates Inflammation and Abdominal Aortic Aneurysm Formation via Several Anti-Inflammatory Pathways.
Nakao T; Horie T; Baba O; Nishiga M; Nishino T; Izuhara M; Kuwabara Y; Nishi H; Usami S; Nakazeki F; Ide Y; Koyama S; Kimura M; Sowa N; Ohno S; Aoki H; Hasegawa K; Sakamoto K; Minatoya K; Kimura T; Ono K
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2161-2170. PubMed ID: 28882868
[TBL] [Abstract][Full Text] [Related]
13. Everolimus limits aortic aneurysm in the apolipoprotein E-deficient mouse by downregulating C-C chemokine receptor 2 positive monocytes.
Moran CS; Jose RJ; Moxon JV; Roomberg A; Norman PE; Rush C; Körner H; Golledge J
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):814-21. PubMed ID: 23393391
[TBL] [Abstract][Full Text] [Related]
14. Ursolic acid prevents angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-knockout mice.
Zhai M; Guo J; Ma H; Shi W; Jou D; Yan D; Liu T; Tao J; Duan J; Wang Y; Li S; Lv J; Li C; Lin J; Zhang C; Lin L
Atherosclerosis; 2018 Apr; 271():128-135. PubMed ID: 29499360
[TBL] [Abstract][Full Text] [Related]
15. Importance of endothelial NF-κB signalling in vascular remodelling and aortic aneurysm formation.
Saito T; Hasegawa Y; Ishigaki Y; Yamada T; Gao J; Imai J; Uno K; Kaneko K; Ogihara T; Shimosawa T; Asano T; Fujita T; Oka Y; Katagiri H
Cardiovasc Res; 2013 Jan; 97(1):106-14. PubMed ID: 23015640
[TBL] [Abstract][Full Text] [Related]
16. Tauroursodeoxycholic Acid Attenuates Angiotensin II Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-deficient Mice by Inhibiting Endoplasmic Reticulum Stress.
Qin Y; Wang Y; Liu O; Jia L; Fang W; Du J; Wei Y
Eur J Vasc Endovasc Surg; 2017 Mar; 53(3):337-345. PubMed ID: 27889204
[TBL] [Abstract][Full Text] [Related]
17. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model.
Spinosa M; Su G; Salmon MD; Lu G; Cullen JM; Fashandi AZ; Hawkins RB; Montgomery W; Meher AK; Conte MS; Sharma AK; Ailawadi G; Upchurch GR
J Vasc Surg; 2018 Dec; 68(6S):93S-103S. PubMed ID: 30470363
[TBL] [Abstract][Full Text] [Related]
18. Factor Xa inhibitor rivaroxaban suppresses experimental abdominal aortic aneurysm progression via attenuating aortic inflammation.
Ding Y; Li X; Zhou M; Cai L; Tang H; Xie T; Shi Z; Fu W
Vascul Pharmacol; 2021 Feb; 136():106818. PubMed ID: 33227452
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm Formation.
Webb NR; De Beer MC; Wroblewski JM; Ji A; Bailey W; Shridas P; Charnigo RJ; Noffsinger VP; Witta J; Howatt DA; Balakrishnan A; Rateri DL; Daugherty A; De Beer FC
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1156-65. PubMed ID: 25745063
[TBL] [Abstract][Full Text] [Related]
20. High serum thrombospondin-1 concentration is associated with slower abdominal aortic aneurysm growth and deficiency of thrombospondin-1 promotes angiotensin II induced aortic aneurysm in mice.
Krishna SM; Seto SW; Jose R; Li J; Moxon J; Clancy P; Crossman DJ; Norman P; Emeto TI; Golledge J
Clin Sci (Lond); 2017 Jun; 131(12):1261-1281. PubMed ID: 28364044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
